Raks Pharma Pvt Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA and WHO-GMP.
One of their notable products is AZATHIOPRINE USP (CODE AZ), with a corresponding US DMF Number 37207.
Remarkably, this DMF maintains an Active status since its submission on June 30, 2022, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of July 29, 2022, and payment made on June 24, 2022, indicating their dedication to facilitating drug approvals, Categorized as Type II